{"id":117,"date":"2025-06-04T07:50:56","date_gmt":"2025-06-04T00:50:56","guid":{"rendered":"https:\/\/pythonsonline.com\/index.php\/2025\/06\/04\/uc-berkeley-awards-200k-venture-grant-ke-hypo2regen-therapeutics\/"},"modified":"2025-06-04T07:50:56","modified_gmt":"2025-06-04T00:50:56","slug":"uc-berkeley-awards-200k-venture-grant-ke-hypo2regen-therapeutics","status":"publish","type":"post","link":"https:\/\/pythonsonline.com\/index.php\/2025\/06\/04\/uc-berkeley-awards-200k-venture-grant-ke-hypo2regen-therapeutics\/","title":{"rendered":"UC Berkeley Awards $ 200k Venture Grant ke Hypo2Regen Therapeutics"},"content":{"rendered":"<div>\n<div class=\"\">\n<div style=\"width:30%;float:left;max-width:525px;margin:0 1.5rem 1.5rem 0;clear:both;cursor:\" class=\" figure\">\n<div id=\"image-caption\" class=\"text-gray-500 italic\">\n<div class=\"blockText_blockContent__TbCXh\">\n<p class=\"pb-2\">Aerial dari Kampus UC Berkeley | Kredit Gambar: \u00a9 Coralimages &#8211; Stock.adobe.com<\/p>\n<\/div>\n<\/div>\n<div class=\"top-(-100%) block w-(1px) transition-opacity duration-500 ease-in-out opacity-0 overflow-hidden\"><img decoding=\"async\" class=\"m-auto absolute inset-0 max-w-(0%) max-h-(0%) border-(3px) border-solid border-white shadow-(0px_0px_8px_rgba(0,0,0,0.3)) box-border transition ease-in-out duration-500\" src=\"https:\/\/cdn.sanity.io\/images\/0vv8moc6\/pharmtech\/ca7cff9ef5dd74f93f7d6d01f35b7af8a5ead5b3-3000x2250.jpg?fit=crop&amp;auto=format\"\/><\/div>\n<\/div>\n<\/div>\n<p class=\"pb-2\">University of California, Berkeley (UC Berkeley) Life Sciences Entrepreneurship Center (LSEC) telah mengumumkan bahwa hypo<sub class=\"text-inherit\">2<\/sub>Regen Therapeutics adalah penerima Program Hibah Ventura 2025, yang menawarkan pendanaan minimal $ 200.000, masuk ke akselerator startup pusat dan pusat kewirausahaan global (Berkeley Skydeck), dan akses ke sumber daya UC Berkeley lainnya (1).<\/p>\n<p class=\"pb-2\">Hypo<sub class=\"text-inherit\">2<\/sub>Misi Regen adalah untuk mengembangkan dan membawa ke pasar baru, terapi pemodifikasi penyakit untuk penyakit radang kronis yang tidak dapat diatasi, terutama termasuk apa yang akan menjadi pengobatan sel induk bebas sel pertama yang menginduksi regenerasi jaringan yang benar yang rusak oleh peradangan kronis (1). Fokus perusahaan saat ini adalah pada peningkatan kehidupan lebih dari 300 juta orang di Amerika Serikat dan Eropa dengan periodontitis sedang hingga berat, hingga 70% di antaranya dapat diawasi atau tidak diobati.<\/p>\n<h2 class=\"text-2xl pb-4 pt-2\"><strong>Rincian pendanaan<\/strong><\/h2>\n<p class=\"pb-2\">Program hibah ventura berada di tahun ketiga, dan pengaturan keuangannya terdiri dari hibah translasi akademik $ 100.000 dari Berkeley LSEC dan investasi $ 100.000 dari Berkeley Skydeck Fund, yang memiliki opsi untuk menginvestasikan $ 100.000 lebih (1). Berkeley Skydeck adalah salah satu akselerator paling kompetitif di dunia (tingkat penerimaan sekitar 1%) menurut universitas, dan hypo<sub class=\"text-inherit\">2<\/sub>Regen akan berpartisipasi dalam kohort batch 20 -nya, yang dimulai 5 Mei 2025.<\/p>\n<p class=\"pb-2\">\u201cUC Berkeley memiliki tradisi pendukung pendukung yang kaya, dengan beberapa perusahaan terkemuka di dunia dan penelitian terpenting yang datang dari kampus kami,\u201d kata Darren Cooke, Kepala Inovasi dan Wirausaha Sementara di UC Berkeley dan direktur eksekutif Berkeley LSEC, dalam siaran pers pada 3 Juni 3, 2025 (1). \u201cProgram Hibah Ventura LSEC melanjutkan warisan itu, dan kami telah melihat hasil yang mengesankan dari penerima perdana kami. Kami sangat senang melihat apa hypo<sub class=\"text-inherit\">2<\/sub>Tim Regen akan mencapai, dan berharap dapat mendukung mereka di setiap langkah perjalanan mereka. \u201d<\/p>\n<h2 class=\"text-2xl pb-4 pt-2\"><strong>Koneksi ke UC Berkeley<\/strong><\/h2>\n<p class=\"pb-2\">Untuk memenuhi syarat untuk Program Hibah Ventura, seorang pelamar harus siap untuk dimasukkan sebagai perusahaan dengan inovasi di bidang Ilmu Kehidupan yang didasarkan pada kekayaan intelektual yang ditemukan di UC Berkeley. Selain itu, tim harus memiliki setidaknya dua anggota dan terhubung ke Berkeley dalam beberapa cara &#8211; apakah personelnya adalah fakultas, mahasiswa PhD, postdocs, atau mahasiswa pascasarjana di salah satu dari beberapa disiplin ilmu (1).<\/p>\n<p class=\"pb-2\">Dalam kasus hypo<sub class=\"text-inherit\">2<\/sub>Regen, perusahaan ini didirikan oleh ketua departemen bioengineering Philip Messersmith dan pengusaha Isabelle Gorrillot.<\/p>\n<p class=\"pb-2\">\u201cProgram Hibah Ventura LSEC telah menjadi tambahan yang menarik bagi Berkeley Skydeck, dan jalur kesehatan Bio+kami telah berperan dalam mendukung penerima hibah saat mereka memulai perjalanan startup mereka,\u201d kata Caroline Winnett, direktur eksekutif Berkeley Skydeck, dalam siaran pers (1). \u201cKami sangat senang menyambut hypo<sub class=\"text-inherit\">2<\/sub>Regen ke kohort batch 20 kami. Terobosan mereka &#8211; terapi sel STEM tanpa sel induk &#8211; memiliki potensi terapi yang benar -benar luar biasa. &#8220;<\/p>\n<h2 class=\"text-2xl pb-4 pt-2\"><strong>Terapi baru yang menarik perhatian<\/strong><\/h2>\n<p class=\"pb-2\">Hibah dari UC Berkeley datang pada saat bentuk -bentuk pemberian obat baru sedang diselidiki dan diuji untuk menilai kelayakannya di seluruh populasi pasien besar. Ini adalah topik <em>Teknologi Farmasi<\/em>\u00ae Mei 2025 &#8220;Podcast Solusi Narkoba.&#8221; Dalam episode itu, Nicholas Giovannone, ilmuwan utama senior di Regeneron, dan Bernie Owusu-yaw, peneliti di Brigham dan Rumah Sakit Wanita di Boston, membahas tantangan yang harus diatasi dalam menggunakan vektor virus adeno (AAV) sebagai mekanisme pengiriman dalam terapi gen (2).<\/p>\n<p class=\"pb-2\">Angsuran podcast itu dapat didengar secara lengkap <em>Teknologi Farmasi<\/em>\u00ae Situs web dan banyak platform media streaming, dan semua episode podcast Solutions Obat sebelumnya juga dapat diakses di pharmtech.com.<\/p>\n<h2 class=\"text-2xl pb-4 pt-2\"><strong>Referensi<\/strong><\/h2>\n<p class=\"pb-2\">1. UC Berkeley. UC Berkeley Life Sciences Entrepreneurship Center mengumumkan 2025 penerima hibah ventura. Siaran pers. 3 Juni 2025.<br \/>2. Lavery, P. P. Podcast Solusi Obat: Pendekatan Pengiriman Obat Baru: Memperbaiki pengiriman vektor AAV. <em>Pharmtech.com<\/em>30 Mei 2025.<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Aerial dari Kampus UC Berkeley | Kredit Gambar: \u00a9 Coralimages &#8211; Stock.adobe.com University of California, Berkeley (UC Berkeley) Life Sciences Entrepreneurship Center (LSEC) telah mengumumkan bahwa hypo2Regen Therapeutics adalah penerima Program Hibah Ventura 2025, yang menawarkan pendanaan minimal $ 200.000, masuk ke akselerator startup pusat dan pusat kewirausahaan global (Berkeley Skydeck), dan akses ke sumber [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":118,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-117","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>UC Berkeley Awards $ 200k Venture Grant ke Hypo2Regen Therapeutics - Nova Anggreni, S.Farm, APT<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pythonsonline.com\/index.php\/2025\/06\/04\/uc-berkeley-awards-200k-venture-grant-ke-hypo2regen-therapeutics\/\" \/>\n<meta property=\"og:locale\" content=\"id_ID\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"UC Berkeley Awards $ 200k Venture Grant ke Hypo2Regen Therapeutics - Nova Anggreni, S.Farm, APT\" \/>\n<meta property=\"og:description\" content=\"Aerial dari Kampus UC Berkeley | Kredit Gambar: \u00a9 Coralimages &#8211; Stock.adobe.com University of California, Berkeley (UC Berkeley) Life Sciences Entrepreneurship Center (LSEC) telah mengumumkan bahwa hypo2Regen Therapeutics adalah penerima Program Hibah Ventura 2025, yang menawarkan pendanaan minimal $ 200.000, masuk ke akselerator startup pusat dan pusat kewirausahaan global (Berkeley Skydeck), dan akses ke sumber [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pythonsonline.com\/index.php\/2025\/06\/04\/uc-berkeley-awards-200k-venture-grant-ke-hypo2regen-therapeutics\/\" \/>\n<meta property=\"og:site_name\" content=\"Nova Anggreni, S.Farm, APT\" \/>\n<meta property=\"article:published_time\" content=\"2025-06-04T00:50:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cdn.sanity.io\/images\/0vv8moc6\/pharmtech\/ca7cff9ef5dd74f93f7d6d01f35b7af8a5ead5b3-3000x2250.jpg?fit=crop&amp;auto=format\" \/>\n<meta name=\"author\" content=\"pythonsonline\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ditulis oleh\" \/>\n\t<meta name=\"twitter:data1\" content=\"pythonsonline\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimasi waktu membaca\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 menit\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pythonsonline.com\/index.php\/2025\/06\/04\/uc-berkeley-awards-200k-venture-grant-ke-hypo2regen-therapeutics\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pythonsonline.com\/index.php\/2025\/06\/04\/uc-berkeley-awards-200k-venture-grant-ke-hypo2regen-therapeutics\/\"},\"author\":{\"name\":\"pythonsonline\",\"@id\":\"https:\/\/pythonsonline.com\/#\/schema\/person\/c1dd578cabc4e398492d9e25f7aff156\"},\"headline\":\"UC Berkeley Awards $ 200k Venture Grant ke Hypo2Regen Therapeutics\",\"datePublished\":\"2025-06-04T00:50:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pythonsonline.com\/index.php\/2025\/06\/04\/uc-berkeley-awards-200k-venture-grant-ke-hypo2regen-therapeutics\/\"},\"wordCount\":573,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/pythonsonline.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/pythonsonline.com\/index.php\/2025\/06\/04\/uc-berkeley-awards-200k-venture-grant-ke-hypo2regen-therapeutics\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pythonsonline.com\/wp-content\/uploads\/2025\/06\/ca7cff9ef5dd74f93f7d6d01f35b7af8a5ead5b3-3000x2250-scaled.jpg\",\"articleSection\":[\"Blog\"],\"inLanguage\":\"id\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pythonsonline.com\/index.php\/2025\/06\/04\/uc-berkeley-awards-200k-venture-grant-ke-hypo2regen-therapeutics\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pythonsonline.com\/index.php\/2025\/06\/04\/uc-berkeley-awards-200k-venture-grant-ke-hypo2regen-therapeutics\/\",\"url\":\"https:\/\/pythonsonline.com\/index.php\/2025\/06\/04\/uc-berkeley-awards-200k-venture-grant-ke-hypo2regen-therapeutics\/\",\"name\":\"UC Berkeley Awards $ 200k Venture Grant ke Hypo2Regen Therapeutics - Nova Anggreni, S.Farm, APT\",\"isPartOf\":{\"@id\":\"https:\/\/pythonsonline.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pythonsonline.com\/index.php\/2025\/06\/04\/uc-berkeley-awards-200k-venture-grant-ke-hypo2regen-therapeutics\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pythonsonline.com\/index.php\/2025\/06\/04\/uc-berkeley-awards-200k-venture-grant-ke-hypo2regen-therapeutics\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pythonsonline.com\/wp-content\/uploads\/2025\/06\/ca7cff9ef5dd74f93f7d6d01f35b7af8a5ead5b3-3000x2250-scaled.jpg\",\"datePublished\":\"2025-06-04T00:50:56+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/pythonsonline.com\/index.php\/2025\/06\/04\/uc-berkeley-awards-200k-venture-grant-ke-hypo2regen-therapeutics\/#breadcrumb\"},\"inLanguage\":\"id\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pythonsonline.com\/index.php\/2025\/06\/04\/uc-berkeley-awards-200k-venture-grant-ke-hypo2regen-therapeutics\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"id\",\"@id\":\"https:\/\/pythonsonline.com\/index.php\/2025\/06\/04\/uc-berkeley-awards-200k-venture-grant-ke-hypo2regen-therapeutics\/#primaryimage\",\"url\":\"https:\/\/pythonsonline.com\/wp-content\/uploads\/2025\/06\/ca7cff9ef5dd74f93f7d6d01f35b7af8a5ead5b3-3000x2250-scaled.jpg\",\"contentUrl\":\"https:\/\/pythonsonline.com\/wp-content\/uploads\/2025\/06\/ca7cff9ef5dd74f93f7d6d01f35b7af8a5ead5b3-3000x2250-scaled.jpg\",\"width\":2560,\"height\":1920},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pythonsonline.com\/index.php\/2025\/06\/04\/uc-berkeley-awards-200k-venture-grant-ke-hypo2regen-therapeutics\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Beranda\",\"item\":\"https:\/\/pythonsonline.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"UC Berkeley Awards $ 200k Venture Grant ke Hypo2Regen Therapeutics\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pythonsonline.com\/#website\",\"url\":\"https:\/\/pythonsonline.com\/\",\"name\":\"Nova Anggreni, S.Farm, APT\",\"description\":\"Keahlian Farmasi Bertemu Kekuatan Python\",\"publisher\":{\"@id\":\"https:\/\/pythonsonline.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pythonsonline.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"id\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/pythonsonline.com\/#organization\",\"name\":\"Nova Anggreni, S.Farm, APT\",\"url\":\"https:\/\/pythonsonline.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"id\",\"@id\":\"https:\/\/pythonsonline.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/pythonsonline.com\/wp-content\/uploads\/2025\/04\/novapylogo.png\",\"contentUrl\":\"https:\/\/pythonsonline.com\/wp-content\/uploads\/2025\/04\/novapylogo.png\",\"width\":1080,\"height\":416,\"caption\":\"Nova Anggreni, S.Farm, APT\"},\"image\":{\"@id\":\"https:\/\/pythonsonline.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/pythonsonline.com\/#\/schema\/person\/c1dd578cabc4e398492d9e25f7aff156\",\"name\":\"pythonsonline\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"id\",\"@id\":\"https:\/\/pythonsonline.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/ce18169fbfa6b96654e8a84f663d2fe6cd783a46c25e8318605272fd245c2e8c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/ce18169fbfa6b96654e8a84f663d2fe6cd783a46c25e8318605272fd245c2e8c?s=96&d=mm&r=g\",\"caption\":\"pythonsonline\"},\"sameAs\":[\"https:\/\/pythonsonline.com\"],\"url\":\"https:\/\/pythonsonline.com\/index.php\/author\/pythonsonline\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"UC Berkeley Awards $ 200k Venture Grant ke Hypo2Regen Therapeutics - Nova Anggreni, S.Farm, APT","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pythonsonline.com\/index.php\/2025\/06\/04\/uc-berkeley-awards-200k-venture-grant-ke-hypo2regen-therapeutics\/","og_locale":"id_ID","og_type":"article","og_title":"UC Berkeley Awards $ 200k Venture Grant ke Hypo2Regen Therapeutics - Nova Anggreni, S.Farm, APT","og_description":"Aerial dari Kampus UC Berkeley | Kredit Gambar: \u00a9 Coralimages &#8211; Stock.adobe.com University of California, Berkeley (UC Berkeley) Life Sciences Entrepreneurship Center (LSEC) telah mengumumkan bahwa hypo2Regen Therapeutics adalah penerima Program Hibah Ventura 2025, yang menawarkan pendanaan minimal $ 200.000, masuk ke akselerator startup pusat dan pusat kewirausahaan global (Berkeley Skydeck), dan akses ke sumber [&hellip;]","og_url":"https:\/\/pythonsonline.com\/index.php\/2025\/06\/04\/uc-berkeley-awards-200k-venture-grant-ke-hypo2regen-therapeutics\/","og_site_name":"Nova Anggreni, S.Farm, APT","article_published_time":"2025-06-04T00:50:56+00:00","og_image":[{"url":"https:\/\/cdn.sanity.io\/images\/0vv8moc6\/pharmtech\/ca7cff9ef5dd74f93f7d6d01f35b7af8a5ead5b3-3000x2250.jpg?fit=crop&amp;auto=format","type":"","width":"","height":""}],"author":"pythonsonline","twitter_card":"summary_large_image","twitter_misc":{"Ditulis oleh":"pythonsonline","Estimasi waktu membaca":"3 menit"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pythonsonline.com\/index.php\/2025\/06\/04\/uc-berkeley-awards-200k-venture-grant-ke-hypo2regen-therapeutics\/#article","isPartOf":{"@id":"https:\/\/pythonsonline.com\/index.php\/2025\/06\/04\/uc-berkeley-awards-200k-venture-grant-ke-hypo2regen-therapeutics\/"},"author":{"name":"pythonsonline","@id":"https:\/\/pythonsonline.com\/#\/schema\/person\/c1dd578cabc4e398492d9e25f7aff156"},"headline":"UC Berkeley Awards $ 200k Venture Grant ke Hypo2Regen Therapeutics","datePublished":"2025-06-04T00:50:56+00:00","mainEntityOfPage":{"@id":"https:\/\/pythonsonline.com\/index.php\/2025\/06\/04\/uc-berkeley-awards-200k-venture-grant-ke-hypo2regen-therapeutics\/"},"wordCount":573,"commentCount":0,"publisher":{"@id":"https:\/\/pythonsonline.com\/#organization"},"image":{"@id":"https:\/\/pythonsonline.com\/index.php\/2025\/06\/04\/uc-berkeley-awards-200k-venture-grant-ke-hypo2regen-therapeutics\/#primaryimage"},"thumbnailUrl":"https:\/\/pythonsonline.com\/wp-content\/uploads\/2025\/06\/ca7cff9ef5dd74f93f7d6d01f35b7af8a5ead5b3-3000x2250-scaled.jpg","articleSection":["Blog"],"inLanguage":"id","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pythonsonline.com\/index.php\/2025\/06\/04\/uc-berkeley-awards-200k-venture-grant-ke-hypo2regen-therapeutics\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pythonsonline.com\/index.php\/2025\/06\/04\/uc-berkeley-awards-200k-venture-grant-ke-hypo2regen-therapeutics\/","url":"https:\/\/pythonsonline.com\/index.php\/2025\/06\/04\/uc-berkeley-awards-200k-venture-grant-ke-hypo2regen-therapeutics\/","name":"UC Berkeley Awards $ 200k Venture Grant ke Hypo2Regen Therapeutics - Nova Anggreni, S.Farm, APT","isPartOf":{"@id":"https:\/\/pythonsonline.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pythonsonline.com\/index.php\/2025\/06\/04\/uc-berkeley-awards-200k-venture-grant-ke-hypo2regen-therapeutics\/#primaryimage"},"image":{"@id":"https:\/\/pythonsonline.com\/index.php\/2025\/06\/04\/uc-berkeley-awards-200k-venture-grant-ke-hypo2regen-therapeutics\/#primaryimage"},"thumbnailUrl":"https:\/\/pythonsonline.com\/wp-content\/uploads\/2025\/06\/ca7cff9ef5dd74f93f7d6d01f35b7af8a5ead5b3-3000x2250-scaled.jpg","datePublished":"2025-06-04T00:50:56+00:00","breadcrumb":{"@id":"https:\/\/pythonsonline.com\/index.php\/2025\/06\/04\/uc-berkeley-awards-200k-venture-grant-ke-hypo2regen-therapeutics\/#breadcrumb"},"inLanguage":"id","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pythonsonline.com\/index.php\/2025\/06\/04\/uc-berkeley-awards-200k-venture-grant-ke-hypo2regen-therapeutics\/"]}]},{"@type":"ImageObject","inLanguage":"id","@id":"https:\/\/pythonsonline.com\/index.php\/2025\/06\/04\/uc-berkeley-awards-200k-venture-grant-ke-hypo2regen-therapeutics\/#primaryimage","url":"https:\/\/pythonsonline.com\/wp-content\/uploads\/2025\/06\/ca7cff9ef5dd74f93f7d6d01f35b7af8a5ead5b3-3000x2250-scaled.jpg","contentUrl":"https:\/\/pythonsonline.com\/wp-content\/uploads\/2025\/06\/ca7cff9ef5dd74f93f7d6d01f35b7af8a5ead5b3-3000x2250-scaled.jpg","width":2560,"height":1920},{"@type":"BreadcrumbList","@id":"https:\/\/pythonsonline.com\/index.php\/2025\/06\/04\/uc-berkeley-awards-200k-venture-grant-ke-hypo2regen-therapeutics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Beranda","item":"https:\/\/pythonsonline.com\/"},{"@type":"ListItem","position":2,"name":"UC Berkeley Awards $ 200k Venture Grant ke Hypo2Regen Therapeutics"}]},{"@type":"WebSite","@id":"https:\/\/pythonsonline.com\/#website","url":"https:\/\/pythonsonline.com\/","name":"Nova Anggreni, S.Farm, APT","description":"Keahlian Farmasi Bertemu Kekuatan Python","publisher":{"@id":"https:\/\/pythonsonline.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pythonsonline.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"id"},{"@type":"Organization","@id":"https:\/\/pythonsonline.com\/#organization","name":"Nova Anggreni, S.Farm, APT","url":"https:\/\/pythonsonline.com\/","logo":{"@type":"ImageObject","inLanguage":"id","@id":"https:\/\/pythonsonline.com\/#\/schema\/logo\/image\/","url":"https:\/\/pythonsonline.com\/wp-content\/uploads\/2025\/04\/novapylogo.png","contentUrl":"https:\/\/pythonsonline.com\/wp-content\/uploads\/2025\/04\/novapylogo.png","width":1080,"height":416,"caption":"Nova Anggreni, S.Farm, APT"},"image":{"@id":"https:\/\/pythonsonline.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pythonsonline.com\/#\/schema\/person\/c1dd578cabc4e398492d9e25f7aff156","name":"pythonsonline","image":{"@type":"ImageObject","inLanguage":"id","@id":"https:\/\/pythonsonline.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/ce18169fbfa6b96654e8a84f663d2fe6cd783a46c25e8318605272fd245c2e8c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ce18169fbfa6b96654e8a84f663d2fe6cd783a46c25e8318605272fd245c2e8c?s=96&d=mm&r=g","caption":"pythonsonline"},"sameAs":["https:\/\/pythonsonline.com"],"url":"https:\/\/pythonsonline.com\/index.php\/author\/pythonsonline\/"}]}},"_links":{"self":[{"href":"https:\/\/pythonsonline.com\/index.php\/wp-json\/wp\/v2\/posts\/117","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pythonsonline.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pythonsonline.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pythonsonline.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/pythonsonline.com\/index.php\/wp-json\/wp\/v2\/comments?post=117"}],"version-history":[{"count":0,"href":"https:\/\/pythonsonline.com\/index.php\/wp-json\/wp\/v2\/posts\/117\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pythonsonline.com\/index.php\/wp-json\/wp\/v2\/media\/118"}],"wp:attachment":[{"href":"https:\/\/pythonsonline.com\/index.php\/wp-json\/wp\/v2\/media?parent=117"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pythonsonline.com\/index.php\/wp-json\/wp\/v2\/categories?post=117"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pythonsonline.com\/index.php\/wp-json\/wp\/v2\/tags?post=117"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}